Market Indices
Sector Heatmap
PFS — Provident Financial Services, Inc.
NYSEProvident Financial Services, Inc.
- O
- 22.04
- H
- 22.11
- L
- 21.80
- V
- 829.44K
PFS — Latest News & Headlines
20 StoriesProvident Financial Services (PFS) Stock May Be 47% Undervalued As Returns Support A Bargain - Yahoo Finance
Provident Financial Services (PFS) Stock May Be 47% Undervalued As Returns Support A Bargain Yahoo Finance
Provident Financial Services (NYSE:PFS) Stock Crosses Above Two Hundred Day Moving Average - Should You Sell? - MarketBeat
Provident Financial Services (NYSE:PFS) Stock Crosses Above Two Hundred Day Moving Average - Should You Sell? MarketBeat
Carotuximab Plus Apalutamide Improves PFS in mCRPC - OncLive
Carotuximab Plus Apalutamide Improves PFS in mCRPC OncLive
Provident expects to release third-quarter results after market close Oct. 28. - Stock Titan
Provident expects to release third-quarter results after market close Oct. 28. Stock Titan
ArriVent’s phase 3 lung cancer trial flops, sinking stock - Fierce Biotech
ArriVent’s phase 3 lung cancer trial flops, sinking stock Fierce Biotech
Epcoritamab/R-CHOP Shows PFS Benefit in Newly Diagnosed DLBCL - CancerNetwork
Epcoritamab/R-CHOP Shows PFS Benefit in Newly Diagnosed DLBCL CancerNetwork
Regional Banks Stocks Q2 Teardown: Provident Financial Services (NYSE:PFS) Vs The Rest - TradingView
Regional Banks Stocks Q2 Teardown: Provident Financial Services (NYSE:PFS) Vs The Rest TradingView
Firmonertinib Misses PFS End Point in EGFR Exon 20–Mutant NSCLC - Targeted Oncology
Firmonertinib Misses PFS End Point in EGFR Exon 20–Mutant NSCLC Targeted Oncology
Regional Banks Stocks Q2 Teardown: Provident Financial Services (NYSE:PFS) Vs The Rest - The Globe and Mail
Regional Banks Stocks Q2 Teardown: Provident Financial Services (NYSE:PFS) Vs The Rest The Globe and Mail
Technical Reactions to PFS Trends in Macro Strategies - Stock Traders Daily
Technical Reactions to PFS Trends in Macro Strategies Stock Traders Daily
Provident Financial Services, Inc. (PFS) stock price, news, quote and history - Yahoo Finance UK
Provident Financial Services, Inc. (PFS) stock price, news, quote and history Yahoo Finance UK
Etentamig Improves Response and PFS vs Standard Therapies in Triple-Class Exposed Relapsed/Refractory Myeloma - OncLive
Etentamig Improves Response and PFS vs Standard Therapies in Triple-Class Exposed Relapsed/Refractory Myeloma OncLive
Student debt worries make trade schools and certificates more appealing to 65% of respondents - Stock Titan
Student debt worries make trade schools and certificates more appealing to 65% of respondents Stock Titan
Phase 2 Data Show PFS Benefit With Carotuximab Combo in mCRPC - Targeted Oncology
Phase 2 Data Show PFS Benefit With Carotuximab Combo in mCRPC Targeted Oncology
Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma - OncLive
Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma OncLive
New quality checks expand Emerita’s review; the project study release is expected in weeks. - Stock Titan
New quality checks expand Emerita’s review; the project study release is expected in weeks. Stock Titan
Epcoritamab Plus R-CHOP Meets PFS End Point in Newly Diagnosed DLBCL - OncLive
Epcoritamab Plus R-CHOP Meets PFS End Point in Newly Diagnosed DLBCL OncLive
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Find Risky - Yahoo Finance
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Find Risky Yahoo Finance
Provident Financial Services (PFS) Is Back In The Spotlight, But Why? - Yahoo Finance
Provident Financial Services (PFS) Is Back In The Spotlight, But Why? Yahoo Finance
Talquetamab Demonstrates Preserved Activity in MonumenTAL-1–Ineligible Patients With Relapsed/Refractory Myeloma - OncLive
Talquetamab Demonstrates Preserved Activity in MonumenTAL-1–Ineligible Patients With Relapsed/Refractory Myeloma OncLive